Home | Endocannabinoids and Autism Spectrum Disorder: Facts, Not Hype

Category: "Lucien Gonzalez, MD, FAAP"

February 6, 2018

Lucien Gonzalez, MD, MS, FAAP, Diplomate of ABAM, University of Minnesota Autism spectrum disorder (ASD) has been added to the list of qualifying medical conditions for Minnesota Medical Cannabis. Patients certified to have ASD will be eligible to enroll in the program on July 1, 2018 and receive cannabis extracts from the state’s approved vendors […]

May 3, 2016

By Pamela Gonzalez, MD The AAP Committee on Substance Abuse (COSA) has officially changed its name to Committee on Substance Use and Prevention (COSUP). This is great news for many reasons, including the elimination of pejorative language (“abuse”). “The Committee on Substance Use and Prevention (COSUP) produces guidance for pediatricians, state and federal government, and […]

June 13, 2015

By Eric Dick, MNAAP Lobbyist, and Pamela Gonzalez, MD, FAAP, Addiction Medicine Specialist at Abound Health and Member of AAP’s Committee on Substance Abuse Few issues garnered more attention during the 2014 legislative session than the effort to authorize the use of marijuana for medicinal purposes. The legislation was the subject of much debate by […]

May 25, 2013

By Pamela K. Gonzalez, MD MS, FAAP, Diplomate ABAM, pediatrician and addiction medicine specialist at Abound Health LLC, adjunct assistant professor at the University of Minnesota and a member of AAP’s Committee on Substance Abuse. While tobacco, alcohol and marijuana remain the most used and abused substances among adolescents, non-medical use (NMU) of prescription medications […]

Annual Sponsors